Assessment of MicroRNA Expression in Acute Graft-versus-Host Disease



Status:Recruiting
Conditions:Hematology
Therapuetic Areas:Hematology
Healthy:No
Age Range:18 - Any
Updated:4/21/2016
Start Date:February 2012
End Date:December 2016
Contact:Ohio State University Comprehensive Cancer Center
Email:Jamesline@osumc.edu
Phone:1-800-293-5066

Use our guide to learn which trials are right for you!

Assessment of MicroRNA Expression in Acute Graft-versus-Host Disease (GVHD).

The purpose of this study is to examine whether the expression levels of a novel class of
molecules, called microRNAs, are associated with acute graft-versus-host disease frequency
and severity. Acute graft-versus-host disease is a Acute GVHD is a medical condition that
can become very serious. It happens when the donor cells attack and damage your tissues
after transplant.

Inclusion Criteria:

- Patients who are receiving allogeneic stem cell transplantation at the Ohio State
University Blood and Marrow Transplantation program are eligible and will be
consented for the study.
We found this trial at
1
site
Columbus, Ohio 43210
Principal Investigator: Yvonne Efebera, MD
Phone: 614-293-2268
?
mi
from
Columbus, OH
Click here to add this to my saved trials